Filing Details
REGENXBIO Inc. (NASDAQ:RGNX) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event.
8k filedNASDAQ:RGNX
REGENXBIO Inc. (RGNX) Reports Material Event to SEC
Filing Details REGENXBIO Inc. (NASDAQ:RGNX) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event. Market Context REGENXBIO…
Market Context
REGENXBIO Inc.'s stock currently trades at $10.32 with a market capitalization of $651.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for REGENXBIO Inc.'s stock.
All SEC filings for REGENXBIO Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RGNX Stock Page
Frequently Asked Questions
Where can I read RGNX's SEC filings?
Browse all filings on our RGNX SEC filings page.
What types of SEC filings does REGENXBIO Inc. file?
Public companies like REGENXBIO Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.